{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:32:01Z","timestamp":1792265521743,"version":"4.4.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalimaging.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Imaging"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.clinimag.2019.10.007","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T12:00:40Z","timestamp":1574424040000},"page":"179-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Evaluation of the modified Van Assche index for assessing response to anti-TNF therapy with MRI in perianal fistulizing Crohn's disease"],"prefix":"10.1016","volume":"59","author":[{"given":"Kyra L.","family":"van Rijn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corine A.","family":"Lansdorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen A.W.","family":"Tielbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Yung","family":"Nio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christianne J.","family":"Buskens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert R.A.M.","family":"D'Haens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"L\u00f6wenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap","family":"Stoker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinimag.2019.10.007_bb0005","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.clinimag.2019.10.007_bb0010","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1053\/gast.2002.32362","article-title":"The natural history of fistulizing Crohn\u2019s disease in Olmsted County","volume":"122","author":"Schwartz","year":"2002","journal-title":"Minnesota Gastroenterology"},{"key":"10.1016\/j.clinimag.2019.10.007_bb0015","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1136\/gutjnl-2013-306709","article-title":"A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn\u2019s disease","volume":"63","author":"Gecse","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.clinimag.2019.10.007_bb0020","doi-asserted-by":"crossref","unstructured":"Lee MJ, Parker CE, Taylor SR, Guizzetti L, Feagan BG, Lobo AJ, et al. Efficacy of Medical Therapies for Fistulizing Crohn's Disease: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 2018;16:1879\u201392. doi:https:\/\/doi.org\/10.1016\/j.cgh.2018.01.030.","DOI":"10.1016\/j.cgh.2018.01.030"},{"key":"10.1016\/j.clinimag.2019.10.007_bb0025","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/nrgastro.2017.104","article-title":"Perianal fistulizing Crohn\u2019s disease: pathogenesis, diagnosis and therapy","volume":"14","author":"Pan\u00e9s","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.clinimag.2019.10.007_bb0030","doi-asserted-by":"crossref","unstructured":"Maaser C, Sturm A, Vavricka SR, Kucharzik T, Fiorino G, Annese V, et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. J Crohn's Colitis 2019;13:144-164K. doi:https:\/\/doi.org\/10.1093\/ecco-jcc\/jjy113.","DOI":"10.1093\/ecco-jcc\/jjy113"},{"key":"10.1016\/j.clinimag.2019.10.007_bb0035","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9270(02)05909-9","article-title":"Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn\u2019s disease","volume":"98","author":"Van Assche","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinimag.2019.10.007_bb0040","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.clinimag.2010.09.003","article-title":"Evaluation of an MRI-based score of disease activity in perianal fistulizing Crohn\u2019s disease","volume":"35","author":"Horsthuis","year":"2011","journal-title":"Clin Imaging"},{"key":"10.1016\/j.clinimag.2019.10.007_bb0045","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1038\/ajg.2009.509","article-title":"Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for crohn\u2019s perineal fistulas","volume":"104","author":"Ng","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinimag.2019.10.007_bb0050","doi-asserted-by":"crossref","unstructured":"Karmiris K, Bielen D, Vanbeckevoort D, Vermeire S, Coremans G, Rutgeerts P, et al. Long-term monitoring of infliximab therapy for perianal fistulizing Crohn's disease by using magnetic resonance imaging. Clin Gastroenterol Hepatol 2011;9:130\u2013136.e1. doi:https:\/\/doi.org\/10.1016\/j.cgh.2010.10.022.","DOI":"10.1016\/j.cgh.2010.10.022"},{"key":"10.1016\/j.clinimag.2019.10.007_bb0055","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1007\/s10620-008-0545-y","article-title":"Predicting factors of fistula healing and clinical remission after infliximab-based combined therapy for perianal fistulizing Crohn\u2019s disease","volume":"54","author":"Tougeron","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinimag.2019.10.007_bb0060","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/ibd.21568","article-title":"Fistulizing perianal Crohn\u2019s disease: contrast-enhanced magnetic resonance imaging assessment at 1 year on maintenance anti-TNF-alpha therapy","volume":"17","author":"Savoye-Collet","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clinimag.2019.10.007_bb0065","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/apt.14190","article-title":"The development of a magnetic resonance imaging index for fistulising Crohn\u2019s disease","volume":"46","author":"Samaan","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinimag.2019.10.007_bb0070","doi-asserted-by":"crossref","unstructured":"Gomoll\u00f3n F, Dignass A, Annese V, Tilg H, Van Assche G, Lindsay JO, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: Part 1: Diagnosis and medical management. J Crohn's Colitis 2017;11:3\u201325. doi:https:\/\/doi.org\/10.1093\/ecco-jcc\/jjw168.","DOI":"10.1093\/ecco-jcc\/jjw168"},{"key":"10.1016\/j.clinimag.2019.10.007_bb0075","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","article-title":"Infliximab for the treatment of fistulas in patients with Crohn\u2019s disease","author":"Present","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinimag.2019.10.007_bb0080","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1148\/radiol.10100252","article-title":"Consensus interpretation in imaging research: is there a better way?","volume":"257","author":"Bankier","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.clinimag.2019.10.007_bb0085","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.clinimag.2019.10.007_bb0090","doi-asserted-by":"crossref","unstructured":"Tozer P, Ng SC, Siddiqui MR, Plamondon S, Burling D, Gupta A, et al. Long-term MRI-guided combined anti-TNF-\u03b1 and thiopurine therapy for Crohn's perianal fistulas. Inflamm Bowel Dis 2012;18:1825\u201334. doi:https:\/\/doi.org\/10.1002\/ibd.21940.","DOI":"10.1002\/ibd.21940"},{"key":"10.1016\/j.clinimag.2019.10.007_bb0095","doi-asserted-by":"crossref","unstructured":"Sturm A, Maaser C, Calabrese E, Annese V, Fiorino G, Kucharzik T, et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects. J Crohn's Colitis 2019;13:273\u201384. doi:https:\/\/doi.org\/10.1093\/ecco-jcc\/jjy114.","DOI":"10.1093\/ecco-jcc\/jjy114"}],"container-title":["Clinical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707119301822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707119301822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:40:51Z","timestamp":1760269251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899707119301822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0899707119301822"],"URL":"https:\/\/doi.org\/10.1016\/j.clinimag.2019.10.007","relation":{},"ISSN":["0899-7071"],"issn-type":[{"value":"0899-7071","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the modified Van Assche index for assessing response to anti-TNF therapy with MRI in perianal fistulizing Crohn's disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinimag.2019.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}